BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9740670)

  • 21. Mutational analysis of the NF2 gene in sporadic meningiomas by denaturing high-performance liquid chromatography.
    Kim JH; Kim IS; Kwon SY; Jang BC; Suh SI; Shin DH; Jeon CH; Son EI; Kim SP
    Int J Mol Med; 2006 Jul; 18(1):27-32. PubMed ID: 16786152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Denaturing high-performance liquid chromatography for mutation detection and genotyping.
    Fackenthal DL; Chen PX; Das S
    Methods Mol Biol; 2005; 311():73-96. PubMed ID: 16100401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of denaturing high performance liquid chromatography (DHPLC) for the mutational analysis of the neurofibromatosis type 1 ( NF1) gene.
    Han SS; Cooper DN; Upadhyaya MN
    Hum Genet; 2001 Nov; 109(5):487-97. PubMed ID: 11735023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid detection of beta-globin gene (HBB) mutations coupling heteroduplex and primer-extension analysis by DHPLC.
    Su YN; Lee CN; Hung CC; Chen CA; Cheng WF; Tsao PN; Yu CL; Hsieh FJ
    Hum Mutat; 2003 Oct; 22(4):326-36. PubMed ID: 12955718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of SSCP and DHPLC for the detection of LDLR mutations in a New Zealand cohort.
    Bunn CF; Lintott CJ; Scott RS; George PM
    Hum Mutat; 2002 Mar; 19(3):311. PubMed ID: 11857755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations.
    Wagner T; Stoppa-Lyonnet D; Fleischmann E; Muhr D; Pagès S; Sandberg T; Caux V; Moeslinger R; Langbauer G; Borg A; Oefner P
    Genomics; 1999 Dec; 62(3):369-76. PubMed ID: 10644434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular genotyping of the Italian cohort of patients with hemophilia B.
    Belvini D; Salviato R; Radossi P; Pierobon F; Mori P; Castaldo G; Tagariello G;
    Haematologica; 2005 May; 90(5):635-42. PubMed ID: 15921378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Random mutagenesis-PCR to introduce alterations into defined DNA sequences for validation of SNP and mutation detection methods.
    Nickerson ML; Warren MB; Zbar B; Schmidt LS
    Hum Mutat; 2001 Mar; 17(3):210-9. PubMed ID: 11241843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Denaturing HPLC for mutation screening.
    Mitchell M; Cutler J
    Methods Mol Biol; 2011; 688():17-33. PubMed ID: 20938830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular analysis in glycogen storage disease 1 non-A: DHPLC detection of the highly prevalent exon 8 mutations of the G6PT1 gene in German patients.
    Santer R; Rischewski J; Block G; Kinner M; Wendel U; Schaub J; Schneppenheim R
    Hum Mutat; 2000 Aug; 16(2):177. PubMed ID: 10923042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of DNA- and RNA-based methods for detection of truncating BRCA1 mutations.
    Andrulis IL; Anton-Culver H; Beck J; Bove B; Boyd J; Buys S; Godwin AK; Hopper JL; Li F; Neuhausen SL; Ozcelik H; Peel D; Santella RM; Southey MC; van Orsouw NJ; Venter DJ; Vijg J; Whittemore AS;
    Hum Mutat; 2002 Jul; 20(1):65-73. PubMed ID: 12112659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid screening of the entire mitochondrial DNA for low-level heteroplasmic mutations.
    Meierhofer D; Mayr JA; Ebner S; Sperl W; Kofler B
    Mitochondrion; 2005 Aug; 5(4):282-96. PubMed ID: 16050991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: a highly efficient and reliable carrier-screening test.
    Su YN; Hung CC; Li H; Lee CN; Cheng WF; Tsao PN; Chang MC; Yu CL; Hsieh WS; Lin WL; Hsu SM
    Hum Mutat; 2005 May; 25(5):460-7. PubMed ID: 15832310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of mutations in the lipoprotein lipase (LPL) and apolipoprotein C-II (APOC2) genes using denaturing high performance liquid chromatography (DHPLC).
    Schuster KB; Wilfert W; Evans D; Thiery J; Teupser D
    Clin Chim Acta; 2011 Jan; 412(3-4):240-4. PubMed ID: 20940006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform.
    Lilleberg SL; Durocher J; Sanders C; Walters K; Culver K
    Ann N Y Acad Sci; 2004 Jun; 1022():250-6. PubMed ID: 15251969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity and specificity of denaturing high-pressure liquid chromatography for unknown protein C gene mutations.
    Taliani MR; Roberts SC; Dukek BA; Pruthi RK; Nichols WL; Heit JA
    Genet Test; 2001; 5(1):39-44. PubMed ID: 11336399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid recognition of aberrant dHPLC elution profiles using the Transgenomic Navigator software.
    Colley J; Jones S; Dallosso AR; Maynard JH; Humphreys V; Dolwani S; Sampson JR; Cheadle JP
    Hum Mutat; 2005 Aug; 26(2):165. PubMed ID: 16010685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of denaturing high performance liquid chromatography (DHPLC) for mutation scanning of hereditary cancer genes.
    Marsh DJ; Howell VM
    Methods Mol Biol; 2010; 653():133-45. PubMed ID: 20721741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Signature-based analysis of MET proto-oncogene mutations using DHPLC.
    Nickerson ML; Weirich G; Zbar B; Schmidt LS
    Hum Mutat; 2000; 16(1):68-76. PubMed ID: 10874308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An optimized DHPLC protocol for molecular testing of the EXT1 and EXT2 genes in hereditary multiple osteochondromas.
    Wuyts W; Radersma R; Storm K; Vits L
    Clin Genet; 2005 Dec; 68(6):542-7. PubMed ID: 16283885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.